Key result
A review of Japanese efforts in stroke management highlights the development of low-dose alteplase for thrombolysis, cilostazol-based dual antiplatelet therapy, and new legislative control acts.
This review summarizes key Japanese contributions to stroke management, including low-dose alteplase and cilostazol-based DAPT, alongside legislative advocacy.
No takes yet. Share an insight, caveat, or question.
Japanese advances in stroke care merit consideration; leaves open their broader applicability pending prospective validation.
A 2022 study conducted a review in Stroke. Stroke prevention and treatment strategies (e.g., low-dose alteplase, cilostazol-based DAPT) was evaluated. A review of Japanese efforts in stroke management highlights the development of low-dose alteplase for thrombolysis, cilostazol-based dual antiplatelet therapy, and new legislative control acts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: